News | January 09, 2025
Evonik partners with South Korean ST Pharm to increase its offerings for RNA and nucleic acid delivery
Increases speed to market for drug developers working on nucleic acid therapeutics
Increases speed to market for drug developers working on nucleic acid therapeutics
This product is categorized as antacids, antiflatulents and anti-Ulcerants
Reconfirms a relative bioavailability of 65 percent and significant savings when using DL-methionine
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Multi-ethnic innovation helps all complexions appear clearer and more uniform
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two additional preclinical programs for other neuroscience indications
Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under CGMP regulations to supply Phase 2 clinical trials
Marksans' OTC Famotidine Tablets USP are acid reducers
Fluor is providing architectural and engineering services and procuring equipment for the new 275,000 square-foot manufacturing facility that will house two manufacturing lines to double manufacturing capability
Subscribe To Our Newsletter & Stay Updated
